Blog

Golden Entertainment (NASDAQ:GDEN), an operator of casinos, hotel rooms, and taverns concentrated in Nevada, released its second quarter 2025 results on August 7, 2025. The main news from the

Dianthus Therapeutics (NASDAQ:DNTH), a clinical-stage biotech developing therapies for autoimmune neuromuscular diseases, reported second quarter results on August 7, 2025. Net loss per share (GAAP)

Fox Factory (NASDAQ:FOXF), a maker of premium suspension systems for bikes, powersports, and vehicles, reported its second quarter fiscal 2025 earnings on August 7, 2025. The most important news

Iovance Biotherapeutics (NASDAQ:IOVA), a biotechnology company specializing in cell therapies for solid tumors, reported GAAP earnings on August 7, 2025. The standout news was a 93% year-over-year

Janux Therapeutics (NASDAQ:JANX), a clinical-stage biotechnology company focused on developing next-generation immunotherapies, reported second quarter results on August 7, 2025. The main headline

Fidus Investment Corporation (NASDAQ:FDUS), a business development company focused on financing lower middle-market companies, released its Q2 2025 earnings results on August 7, 2025. The company

SenesTech (NASDAQ:SNES), a biotechnology company specializing in non-lethal fertility control solutions for rodents, announced its Q2 fiscal 2025 earnings on August 7, 2025. The company reported

Cidara Therapeutics (NASDAQ:CDTX), a biotechnology company focused on the development of innovative therapies for infectious diseases and oncology, released its second-quarter 2025 earnings on

Yelp (NYSE:YELP), an online platform connecting consumers with local businesses through reviews and advertising, reported its Q2 2025 results on August 7, 2025. The most notable news was that the

Rani Therapeutics (NASDAQ:RANI), a biotech company developing oral biologic drug delivery technology, released its earnings for the second quarter of fiscal 2025 on August 7, 2025. Marking an

Nerdy (NYSE:NRDY), the online learning platform behind Varsity Tutors, released its second quarter results on August 7, 2025. The earnings report showed total GAAP revenue of $45.3 million, slightly

Alpha Teknova (NASDAQ:TKNO), a specialist in custom bioprocess solutions for the life sciences sector, released its results on August 7, 2025. The most important news: Revenue (GAAP) rose by 7%

Dorchester Minerals (NASDAQ:DMLP), a Dallas-based owner of oil and natural gas mineral and royalty interests, reported sharply lower results. Released on August 7, 2025, the earnings revealed a

Inseego (NASDAQ:INSG), a wireless networking provider focused on 5G and fixed wireless access technology, announced its results for the fiscal second quarter ended June 30, 2025, on Aug. 7, 2025

Skye Bioscience (NASDAQ:SKYE), a biotechnology company developing novel obesity therapeutics, released its second quarter earnings on August 7, 2025. As in prior quarters, no commercial revenue was

IN8bio (NASDAQ:INAB), a clinical-stage biotechnology company focused on developing gamma-delta T cell therapies for cancer and autoimmune diseases, released its second quarter results on August 7

System1 (NYSE:SST), a digital marketing and technology company focused on privacy-centric search, couponing, and online mapping products, released its earnings for the second quarter of fiscal 2025

Piedmont Lithium (NASDAQ:PLL), a North American lithium developer and producer, released its financial results for Q2 2025 on August 7, 2025. The key highlight was a narrower adjusted

BioAtla (NASDAQ:BCAB), a clinical-stage biotech developing therapies for hard-to-treat cancers, released its second quarter 2025 results on August 7, 2025. The company posted a net loss per share of

Consensus Cloud Solutions (NASDAQ:CCSI), a company specializing in secure digital cloud fax and healthcare data interoperability, released its second quarter results for fiscal 2025 on August 7

Image source: The Motley Fool.

Thursday, August 7, 2025, at 1:00 p.m. ET

Need a quote from a Motley Fool analyst? Email [email protected]

Continue reading

Source Fool.com

Gogo (NASDAQ:GOGO), an aviation connectivity company serving business, military, and government markets, reported Q2 2025 earnings on August 7, 2025. The key news was a large year-over-year increase

Cytokinetics (NASDAQ:CYTK), a late-stage biopharmaceutical company focused on cardiovascular disease, reported earnings for Q2 FY2025 on August 7, 2025. The headline news was a dramatic

Corvus Pharmaceuticals (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on developing immunology and oncology therapies, released its earnings results for Q2 2025 on August 7, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT), a biotechnology company focused on gene therapies for rare and serious diseases, reported its second quarter 2025 results on August 7, 2025. The most